FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/02/062179 [Registered on: 01/02/2024] Trial Registered Prospectively
Last Modified On: 23/01/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Medical Device
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparision of Buska mask over I-Gel LMA in laproscopic gynaecological procedure 
Scientific Title of Study   A Randomised Clinical study To Compare BASKA MASK Vs I-GEL in Female Patients undergoing Diagnostic Laproscopic Gynaecological surgeries under General Anaesthesia 
Trial Acronym  nill 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Beena Thada 
Designation  Associate Proffesor  
Affiliation  JLN medical college ajmer 
Address  Department of anaesthesiology New OT 1st floor Jawahar Lal nehru Medical College and hospital Ajmer

Ajmer
RAJASTHAN
305001
India 
Phone  9352260425  
Fax    
Email  drbeenaverma@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Beena Thada 
Designation  Associate Proffesor  
Affiliation  JLN medical college ajmer 
Address  Department of Anaesthesiology Neo OT 1st floor Jawahar Lal Nehru Medical College and hospitals Ajmer

Ajmer
RAJASTHAN
305001
India 
Phone  9352260425  
Fax    
Email  drbeenaverma@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Beena Thada 
Designation  Associate Proffesor  
Affiliation  JLN medical college ajmer 
Address  Department of Anaesthesiology New OT 1st floor Jawahar Lal Nehru medical college and Hospital Ajmer

Ajmer
RAJASTHAN
305001
India 
Phone  9352260425  
Fax    
Email  drbeenaverma@gmail.com  
 
Source of Monetary or Material Support  
department of anaesthesiology JLN medical collge Ajmer 
 
Primary Sponsor  
Name  Deparrment of anaesthesiology JLN medical college 
Address  New OT first floor JLN medical Hospital kala bagh ajmer rajasthan pin code 305001 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrMahesh  zanana hospital  Zanana OT department of anaesthesiology 1st floor Zanana hospital lohagal, ajmer
Ajmer
RAJASTHAN 
8607159437

mudgalmahesh007@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
institutional ethical committee Jawahar lal nehru medical college ajmer  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N838||Other noninflammatory disorders ofovary, fallopian tube and broad ligament,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  BASKA LMA  Upon arrival in operation theatre, the written informed consent, PAC, and nil per oral status will be confirmed. Study population (100) will be randomly divided into two groups by opaque sealed envelope technique. The Baska Mask will be lubricated and introduced into the mouth toward the hard palate and advanced downward until resistance felt.As an one time procedure and kept throughout the procedure. patients will be monitored for mean airway leak pressure, ease of insertion, peak airway pressure throughout procedure till mask is removed and postoperative complication 
Comparator Agent  I-GEL LMA  Upon arrival in operation theatre, the written informed consent, PAC, and nil per oral status will be confirmed. Study population (100) will be randomly divided into two groups by opaque sealed envelope technique.while inserting I-GEL the tip of the I-Gel will be introduced into the mouth of the patient against the hard palate, avoiding the tongue, and glided downward and backward until a definitive resistance will be felt.As a one time insertion and kept in place throughout the procedure.patients will be monitored for mean airway leak pressure, ease of insertion, peak airway pressure throughout the procedure till it is removed and postoperative complication 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details 
1. Adult female of 20-40yrs age group
2. Weight of 30-60kgs
3. ASA grade I and II
4. Undergoing Diagnostic laproscopic gynaecological surgeries under
general anaesthesia.
5. Surgeries lasting upto 60 minutes. 
 
ExclusionCriteria 
Details  1.known airway difficulty
2.mouth opening less than 2.5 cm
3.obesity
4.negative patient consent
 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
To compare the mean Oropharyngeal Leak Pressure(OLP) just after
successful insertion and 10 minutes after creating pneumoperitoneum.  
just after successful insertion of LMA, at 10 mnts after creating pneumoperitoneum 
 
Secondary Outcome  
Outcome  TimePoints 
1.to compare ease of insertion
2.to compare peak airway pressure
3.post operative complication 
1.at the time of insertion
2.before , during and just after creating pneumoperitoneum
3.immediate postoperative 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   06/02/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Upon arrival in operation theatre, the written informed consent, PAC, and nil per oral status will be confirmed. Study population (100) will be randomly divided into two groups by opaque sealed envelope technique. Group B (n=50) will receive Baska Mask and Group I(n=50) will receive I-Gel.
 In case of securing the airway with supraglottic airway device while using Baska Mask, the patient will be placed in sniffing position. The Baska Mask will be lubricated and introduced into the mouth toward the hard palate and advanced downward until resistance felt. while using  I-GEL . The tip of the I-Gel will be introduced into the mouth of the patient against the hard palate, avoiding the tongue, and glided downward and backward until a definitive resistance will be felt. patient will be monitored for mean oropharyngeal leak pressure as primary objective and ease of insertion, peak airway pressure and  post operative complication as secondary objective. data will be collected and analysed using standard tests , p value of less than 0.05 will be considered significant
 
Close